Drug intelligence / Profile preview

I-125 sodium iodide (Izotop)

Development stage
Unknown
Lead developer
Izotop
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Interstitial
01

Overview

I-125 sodium iodide is a high-purity radiochemical and radiopharmaceutical precursor produced by the Institute of Isotopes Co. (Izotop). It consists of the radioisotope iodine-125 in the form of sodium iodide, supplied as a clear, colorless solution in dilute sodium hydroxide. I-125 decays via electron capture with a half-life of approximately 59.4 days, emitting low-energy gamma radiation (35 keV) and characteristic X-rays. While primarily used as a precursor for labeling compounds in research and pharmaceutical manufacturing, I-125-labeled products are utilized in brachytherapy for various cancers (including prostate cancer, uveal melanomas, and brain tumors), in vitro diagnostic assays such as radioimmunoassays, and diagnostic procedures such as glomerular filtration rate (GFR) measurement for kidney disease assessment.

Other names
I-125 NaI solutionI125 NaI solutionI 125 NaI solutionIodine-125 sodium iodideIodine125 sodium iodideIodine 125 sodium iodideSodium iodide (125I)I-125 sodium iodide solutionI125 sodium iodide solutionI 125 sodium iodide solution
02

Targets

DNA

Beyond the preview

Go deeper on I-125 sodium iodide (Izotop).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on I-125 sodium iodide (Izotop).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call